Skip to content
GLP-1 Desk
Menu
Dispatch #213

MediRX

MediRX is a telehealth weight-loss platform offering compounded GLP-1 injections — semaglutide starting at $149/month and tirzepatide starting at $199/month — plus NAD+ and a name-brand GLP-1 option.

Visit MediRXAssume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way.
Semaglutide
$149/mo (compounded)
Tirzepatide
$199/mo (compounded)
Coverage
Coverage not published
Brand-name
Yes

Weigh MediRX against the full ranked field on the best semaglutide providers board, or line it up against its closest alternatives. Or go one-on-one: MediRX vs CoreAge Rx.

Desk Score breakdown

Each of the six scored dimensions. See the methodology.

Price transparency68/100
State access24/100
Molecule range79/100
Onboarding speed75/100
Support responsiveness78/100
Licensing & trust79/100

What the Desk likes

  • LegitScript Certified — a meaningful trust signal for an online pharmacy
  • Named operating entity disclosed (MediRX, Inc., Wyoming)
  • Care and pharmacy fulfillment run on OpenLoop Health's licensed network
  • Low promotional first-month pricing — semaglutide first month as low as $70

Where points come off

  • Doesn't publish the exact states it serves; telehealth rules vary by state
  • Ongoing monthly price rises after the promotional first month
  • Compounded semaglutide and tirzepatide injections — limited oral options
  • Specific compounding pharmacies aren't named beyond the OpenLoop network

The Desk's briefing — C

Best for: People wanting LegitScript-certified compounded GLP-1 with low first-month promo pricing.

MediRX ranks #213 of 498 providers scored — see #1, CoreAge Rx on the board.

Related dispatches

Everyone else on the board (24)

Pricing and verification reflect MediRX's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on MediRX's site. Not medical advice; see our disclosure.

← Back to The Desk